Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Active Pharmaceutical Ingredient Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Active Pharmaceutical Ingredient Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Type
    • 1.4.2 Synthetic API
    • 1.4.3 Biotech API
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Application
    • 1.5.2 Chemical
    • 1.5.3 Deodorant
    • 1.5.4 Dailylife
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Active Pharmaceutical Ingredient Market Size, Estimates and Forecasts
    • 2.1.1 Global Active Pharmaceutical Ingredient Revenue 2015-2026
    • 2.1.2 Global Active Pharmaceutical Ingredient Sales 2015-2026
  • 2.2 Global Active Pharmaceutical Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Active Pharmaceutical Ingredient Competitor Landscape by Players

  • 3.1 Active Pharmaceutical Ingredient Sales by Manufacturers
    • 3.1.1 Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020)
    • 3.1.2 Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Active Pharmaceutical Ingredient Revenue by Manufacturers
    • 3.2.1 Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
    • 3.2.2 Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredient Revenue in 2019
    • 3.2.5 Global Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Active Pharmaceutical Ingredient Price by Manufacturers
  • 3.4 Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
    • 3.4.1 Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Active Pharmaceutical Ingredient Product Type
    • 3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredient Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Active Pharmaceutical Ingredient Market Size by Type (2015-2020)
    • 4.1.1 Global Active Pharmaceutical Ingredient Sales by Type (2015-2020)
    • 4.1.2 Global Active Pharmaceutical Ingredient Revenue by Type (2015-2020)
    • 4.1.3 Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
    • 4.2.3 Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Active Pharmaceutical Ingredient Market Size by Application (2015-2020)
    • 5.1.1 Global Active Pharmaceutical Ingredient Sales by Application (2015-2020)
    • 5.1.2 Global Active Pharmaceutical Ingredient Revenue by Application (2015-2020)
    • 5.1.3 Active Pharmaceutical Ingredient Price by Application (2015-2020)
  • 5.2 Active Pharmaceutical Ingredient Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Active Pharmaceutical Ingredient by Country
    • 6.1.1 North America Active Pharmaceutical Ingredient Sales by Country
    • 6.1.2 North America Active Pharmaceutical Ingredient Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Active Pharmaceutical Ingredient Market Facts & Figures by Type
  • 6.3 North America Active Pharmaceutical Ingredient Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Active Pharmaceutical Ingredient by Country
    • 7.1.1 Europe Active Pharmaceutical Ingredient Sales by Country
    • 7.1.2 Europe Active Pharmaceutical Ingredient Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Active Pharmaceutical Ingredient Market Facts & Figures by Type
  • 7.3 Europe Active Pharmaceutical Ingredient Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Active Pharmaceutical Ingredient by Region
    • 8.1.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Region
    • 8.1.2 Asia Pacific Active Pharmaceutical Ingredient Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Active Pharmaceutical Ingredient Market Facts & Figures by Type
  • 8.3 Asia Pacific Active Pharmaceutical Ingredient Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Active Pharmaceutical Ingredient by Country
    • 9.1.1 Latin America Active Pharmaceutical Ingredient Sales by Country
    • 9.1.2 Latin America Active Pharmaceutical Ingredient Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Active Pharmaceutical Ingredient Market Facts & Figures by Type
  • 9.3 Central & South America Active Pharmaceutical Ingredient Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Active Pharmaceutical Ingredient by Country
    • 10.1.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Country
    • 10.1.2 Middle East and Africa Active Pharmaceutical Ingredient Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Active Pharmaceutical Ingredient Market Facts & Figures by Type
  • 10.3 Middle East and Africa Active Pharmaceutical Ingredient Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Teva
    • 11.1.1 Teva Corporation Information
    • 11.1.2 Teva Description and Business Overview
    • 11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Teva Active Pharmaceutical Ingredient Products Offered
    • 11.1.5 Teva Related Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description and Business Overview
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Active Pharmaceutical Ingredient Products Offered
    • 11.2.5 Novartis Related Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Description and Business Overview
    • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Pfizer Active Pharmaceutical Ingredient Products Offered
    • 11.3.5 Pfizer Related Developments
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Corporation Information
    • 11.4.2 Johnson & Johnson Description and Business Overview
    • 11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Johnson & Johnson Active Pharmaceutical Ingredient Products Offered
    • 11.4.5 Johnson & Johnson Related Developments
  • 11.5 Mylan
    • 11.5.1 Mylan Corporation Information
    • 11.5.2 Mylan Description and Business Overview
    • 11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan Active Pharmaceutical Ingredient Products Offered
    • 11.5.5 Mylan Related Developments
  • 11.6 North China Pharmaceutical Group
    • 11.6.1 North China Pharmaceutical Group Corporation Information
    • 11.6.2 North China Pharmaceutical Group Description and Business Overview
    • 11.6.3 North China Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 North China Pharmaceutical Group Active Pharmaceutical Ingredient Products Offered
    • 11.6.5 North China Pharmaceutical Group Related Developments
  • 11.7 Dr. Reddy’s Laboratories
    • 11.7.1 Dr. Reddy’s Laboratories Corporation Information
    • 11.7.2 Dr. Reddy’s Laboratories Description and Business Overview
    • 11.7.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Products Offered
    • 11.7.5 Dr. Reddy’s Laboratories Related Developments
  • 11.8 Roche
    • 11.8.1 Roche Corporation Information
    • 11.8.2 Roche Description and Business Overview
    • 11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Roche Active Pharmaceutical Ingredient Products Offered
    • 11.8.5 Roche Related Developments
  • 11.9 Aurobindo pharma
    • 11.9.1 Aurobindo pharma Corporation Information
    • 11.9.2 Aurobindo pharma Description and Business Overview
    • 11.9.3 Aurobindo pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Aurobindo pharma Active Pharmaceutical Ingredient Products Offered
    • 11.9.5 Aurobindo pharma Related Developments
  • 11.10 Sun Pharmaceutical Industries
    • 11.10.1 Sun Pharmaceutical Industries Corporation Information
    • 11.10.2 Sun Pharmaceutical Industries Description and Business Overview
    • 11.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Products Offered
    • 11.10.5 Sun Pharmaceutical Industries Related Developments
  • 11.1 Teva
    • 11.1.1 Teva Corporation Information
    • 11.1.2 Teva Description and Business Overview
    • 11.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Teva Active Pharmaceutical Ingredient Products Offered
    • 11.1.5 Teva Related Developments
  • 11.12 Bayer
    • 11.12.1 Bayer Corporation Information
    • 11.12.2 Bayer Description and Business Overview
    • 11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Bayer Products Offered
    • 11.12.5 Bayer Related Developments
  • 11.13 BASF
    • 11.13.1 BASF Corporation Information
    • 11.13.2 BASF Description and Business Overview
    • 11.13.3 BASF Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 BASF Products Offered
    • 11.13.5 BASF Related Developments
  • 11.14 DSM
    • 11.14.1 DSM Corporation Information
    • 11.14.2 DSM Description and Business Overview
    • 11.14.3 DSM Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 DSM Products Offered
    • 11.14.5 DSM Related Developments
  • 11.15 Zhejiang Medicine
    • 11.15.1 Zhejiang Medicine Corporation Information
    • 11.15.2 Zhejiang Medicine Description and Business Overview
    • 11.15.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Zhejiang Medicine Products Offered
    • 11.15.5 Zhejiang Medicine Related Developments
  • 11.16 Biocon
    • 11.16.1 Biocon Corporation Information
    • 11.16.2 Biocon Description and Business Overview
    • 11.16.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Biocon Products Offered
    • 11.16.5 Biocon Related Developments
  • 11.17 Johnson Matthey
    • 11.17.1 Johnson Matthey Corporation Information
    • 11.17.2 Johnson Matthey Description and Business Overview
    • 11.17.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Johnson Matthey Products Offered
    • 11.17.5 Johnson Matthey Related Developments
  • 11.18 Hisun Pharmacy
    • 11.18.1 Hisun Pharmacy Corporation Information
    • 11.18.2 Hisun Pharmacy Description and Business Overview
    • 11.18.3 Hisun Pharmacy Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Hisun Pharmacy Products Offered
    • 11.18.5 Hisun Pharmacy Related Developments
  • 11.19 Cambrex
    • 11.19.1 Cambrex Corporation Information
    • 11.19.2 Cambrex Description and Business Overview
    • 11.19.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Cambrex Products Offered
    • 11.19.5 Cambrex Related Developments
  • 11.20 Shandong Xinhua Pharmaceutical
    • 11.20.1 Shandong Xinhua Pharmaceutical Corporation Information
    • 11.20.2 Shandong Xinhua Pharmaceutical Description and Business Overview
    • 11.20.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Shandong Xinhua Pharmaceutical Products Offered
    • 11.20.5 Shandong Xinhua Pharmaceutical Related Developments
  • 11.21 Lonza group
    • 11.21.1 Lonza group Corporation Information
    • 11.21.2 Lonza group Description and Business Overview
    • 11.21.3 Lonza group Sales, Revenue and Gross Margin (2015-2020)
    • 11.21.4 Lonza group Products Offered
    • 11.21.5 Lonza group Related Developments
  • 11.22 Huahai Pharmaceutical
    • 11.22.1 Huahai Pharmaceutical Corporation Information
    • 11.22.2 Huahai Pharmaceutical Description and Business Overview
    • 11.22.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.22.4 Huahai Pharmaceutical Products Offered
    • 11.22.5 Huahai Pharmaceutical Related Developments
  • 11.23 Haerbin Pharmaceutical Group
    • 11.23.1 Haerbin Pharmaceutical Group Corporation Information
    • 11.23.2 Haerbin Pharmaceutical Group Description and Business Overview
    • 11.23.3 Haerbin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.23.4 Haerbin Pharmaceutical Group Products Offered
    • 11.23.5 Haerbin Pharmaceutical Group Related Developments
  • 11.24 Cipla
    • 11.24.1 Cipla Corporation Information
    • 11.24.2 Cipla Description and Business Overview
    • 11.24.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.24.4 Cipla Products Offered
    • 11.24.5 Cipla Related Developments
  • 11.25 Tian Yao
    • 11.25.1 Tian Yao Corporation Information
    • 11.25.2 Tian Yao Description and Business Overview
    • 11.25.3 Tian Yao Sales, Revenue and Gross Margin (2015-2020)
    • 11.25.4 Tian Yao Products Offered
    • 11.25.5 Tian Yao Related Developments
  • 11.26 Lupin
    • 11.26.1 Lupin Corporation Information
    • 11.26.2 Lupin Description and Business Overview
    • 11.26.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
    • 11.26.4 Lupin Products Offered
    • 11.26.5 Lupin Related Developments
  • 11.27 North East Pharmaceutical
    • 11.27.1 North East Pharmaceutical Corporation Information
    • 11.27.2 North East Pharmaceutical Description and Business Overview
    • 11.27.3 North East Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.27.4 North East Pharmaceutical Products Offered
    • 11.27.5 North East Pharmaceutical Related Developments
  • 11.28 Albemarle
    • 11.28.1 Albemarle Corporation Information
    • 11.28.2 Albemarle Description and Business Overview
    • 11.28.3 Albemarle Sales, Revenue and Gross Margin (2015-2020)
    • 11.28.4 Albemarle Products Offered
    • 11.28.5 Albemarle Related Developments
  • 11.29 Shandong Lukang Pharmaceutical
    • 11.29.1 Shandong Lukang Pharmaceutical Corporation Information
    • 11.29.2 Shandong Lukang Pharmaceutical Description and Business Overview
    • 11.29.3 Shandong Lukang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.29.4 Shandong Lukang Pharmaceutical Products Offered
    • 11.29.5 Shandong Lukang Pharmaceutical Related Developments
  • 11.30 Jiangsu Hengrui Medicine
    • 11.30.1 Jiangsu Hengrui Medicine Corporation Information
    • 11.30.2 Jiangsu Hengrui Medicine Description and Business Overview
    • 11.30.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
    • 11.30.4 Jiangsu Hengrui Medicine Products Offered
    • 11.30.5 Jiangsu Hengrui Medicine Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Active Pharmaceutical Ingredient Market Estimates and Projections by Region
    • 12.1.1 Global Active Pharmaceutical Ingredient Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Regions 2021-2026
  • 12.2 North America Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
    • 12.2.1 North America: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
    • 12.2.2 North America: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
    • 12.2.3 North America: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
    • 12.3.2 Europe: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Active Pharmaceutical Ingredient Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Active Pharmaceutical Ingredient Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Active Pharmaceutical Ingredient Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Active Pharmaceutical Ingredient market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Active Pharmaceutical Ingredient market is segmented into
    Synthetic API
    Biotech API
    Other

    Segment by Application, the Active Pharmaceutical Ingredient market is segmented into
    Chemical
    Deodorant
    Dailylife

    Regional and Country-level Analysis
    The Active Pharmaceutical Ingredient market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Active Pharmaceutical Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Active Pharmaceutical Ingredient Market Share Analysis
    Active Pharmaceutical Ingredient market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Active Pharmaceutical Ingredient business, the date to enter into the Active Pharmaceutical Ingredient market, Active Pharmaceutical Ingredient product introduction, recent developments, etc.

    The major vendors covered:
    Teva
    Novartis
    Pfizer
    Johnson & Johnson
    Mylan
    North China Pharmaceutical Group
    Dr. Reddy’s Laboratories
    Roche
    Aurobindo pharma
    Sun Pharmaceutical Industries
    Boehringer Ingelheim GmbH
    Bayer
    BASF
    DSM
    Zhejiang Medicine
    Biocon
    Johnson Matthey
    Hisun Pharmacy
    Cambrex
    Shandong Xinhua Pharmaceutical
    Lonza group
    Huahai Pharmaceutical
    Haerbin Pharmaceutical Group
    Cipla
    Tian Yao
    Lupin
    North East Pharmaceutical
    Albemarle
    Shandong Lukang Pharmaceutical
    Jiangsu　Hengrui Medicine

    Buy now